Browsing "1. Journal Papers" by Author : 3436

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 11 of 11

This table browses all dspace content
Issue DateTitleJournal Title
2023Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience JOURNAL OF GYNECOLOGIC ONCOLOGY
2017BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patientsGYNECOLOGIC ONCOLOGY
2017Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients CANCER RESEARCH AND TREATMENT
2018Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2 CANCER RESEARCH AND TREATMENT
2018Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' ExonsAnticancer Research
2022Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer FRONTIERS IN ONCOLOGY
2017Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls CANCER RESEARCH AND TREATMENT
2023Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian CancerCLINICAL CANCER RESEARCH
2023RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma JOURNAL OF GYNECOLOGIC ONCOLOGY
2024Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian CancerCANCER RESEARCH
2018Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer BMC CANCER
1

Browse

Links